Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
D. Guerra, T. Beaumont, L. Radic…·M. J. van Gils
This study identifies broadly neutralizing monoclonal and bispecific antibodies from a Gamma variant-infected individual that effectively neutralize multiple SARS-CoV-2 variants.
P. J. M. Brouwer, A. Antanasijevic, A. J. Ronk…·R. W. Sanders
This study develops Lassa virus glycoprotein nanoparticles that stabilize GPC trimers and elicit neutralizing antibodies targeting a new vulnerability site.
M. Claireaux, T. G. Caniels, M. de Gast…·M. J. van Gils
The paper identifies a novel S2 epitope recognized by a public antibody class in SARS-CoV-2-reactive B cells, which becomes exposed on vaccine-optimized spike proteins.
P. J. M. Brouwer, M. Brinkkemper, P. Maisonnasse…·de Bree
This paper develops a two-component spike nanoparticle vaccine that protects macaques from SARS-CoV-2 infection by inducing strong neutralizing antibodies and reducing viral replication.
P. Brouwer, T. Caniels, K. van Straten…·M. van Gils
This study isolates potent neutralizing antibodies from COVID-19 patients that target multiple sites on the SARS-CoV-2 spike protein, offering insights for vaccine design and therapeutic development.